← Leaderboards
Frederick F Lang
Introgen Therapeutics, Inc.
$11,903,884
Attributed
$11,903,884
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,122,933 · 12
By mechanism
P50$30,222,162 · 7
R01$6,693,326 · 4
R41$207,445 · 1
Top collaborators
- Juan Fueyo7 shared
Others in their field
Top investigators on “Brain Neoplasms”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- David Heimbrook · Leidos Biomedical Research, Inc.$145,442,397
- Walter John Curran · Thomas Jefferson University$98,312,615
- Gregory H Reaman · National Childhood Cancer Foundation$78,833,655
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Robert H Vonderheide · University Of Pennsylvania$60,987,353
Research focus
Brain NeoplasmsMalignant Neoplasm Of BrainGliomaAnimalsTranslational ResearchResearch PersonnelProgramsBaseResourcesSuccessTumorBiologicalPathologyMultidisciplinaryBiobankClinical TrialsBioinformaticsGrantOncolytic VirusesGlioblastomaImmuneResearch Project GrantsClinicUniversity Of Texas M D Anderson Cancer Center
Grant awards (60)
SPORE in Brain Cancer$2,171,252
P50 · FY2025 · CA · contact PI
Administrative Core (Core A)$201,791
P50 · FY2025 · CA · contact PI
SPORE in Brain Cancer$2,088,365
P50 · FY2024 · CA · contact PI
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma$431,749
R01 · FY2024 · CA · contact PI
Administrative Core (Core A)$209,382
P50 · FY2024 · CA · contact PI
SPORE in Brain Cancer$2,051,421
P50 · FY2023 · CA · contact PI
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma$445,383
R01 · FY2023 · CA · contact PI
SPORE in Brain Cancer$2,051,421
P50 · FY2022 · CA · contact PI
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma$445,383
R01 · FY2022 · CA · contact PI
MSC-Derived Exosomes and MicroRNA in Glioma Therapy$358,680
R01 · FY2022 · CA · contact PI
Oncolytic Adenoviruses for Glioma Therapy$315,315
P50 · FY2022 · CA · contact PI
Administrative Core (Core A)$230,352
P50 · FY2022 · CA · contact PI
SPORE in Brain Cancer$2,051,421
P50 · FY2021 · CA · contact PI
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma$454,473
R01 · FY2021 · CA · contact PI
MSC-Derived Exosomes and MicroRNA in Glioma Therapy$366,000
R01 · FY2021 · CA · contact PI
Oncolytic Adenoviruses for Glioma Therapy$275,178
P50 · FY2021 · CA · contact PI
Administrative Core (Core A)$201,031
P50 · FY2021 · CA · contact PI
SPORE in Brain Cancer$2,094,780
P50 · FY2020 · CA · contact PI
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma$454,473
R01 · FY2020 · CA · contact PI
MSC-Derived Exosomes and MicroRNA in Glioma Therapy$366,000
R01 · FY2020 · CA · contact PI
Oncolytic Adenoviruses for Glioma Therapy$327,149
P50 · FY2020 · CA · contact PI
Administrative Core (Core A)$235,694
P50 · FY2020 · CA · contact PI
SPORE in Brain Cancer$2,069,263
P50 · FY2019 · CA · contact PI
MSC-Derived Exosomes and MicroRNA in Glioma Therapy$355,019
R01 · FY2019 · CA · contact PI
Oncolytic Adenoviruses for Glioma Therapy$315,660
P50 · FY2019 · CA · contact PI
Administrative Core (Core A)$230,600
P50 · FY2019 · CA · contact PI
MSC-Derived Exosomes and MicroRNA in Glioma Therapy$366,000
R01 · FY2018 · CA · contact PI
SPORE in Brain Cancer$2,199,333
P50 · FY2017 · CA · contact PI
Administrative Core$174,272
P50 · FY2017 · CA · contact PI
Developmental Research Program$145,682
P50 · FY2017 · CA · contact PI
SPORE in Brain Cancer$89,600
P50 · FY2017 · CA · contact PI
SPORE in Brain Cancer$2,063,541
P50 · FY2016 · CA · contact PI
Administrative Core$163,512
P50 · FY2016 · CA · contact PI
Developmental Research Program$136,687
P50 · FY2016 · CA · contact PI
SPORE in Brain Cancer$89,600
P50 · FY2016 · CA · contact PI
SPORE in Brain Cancer$2,089,360
P50 · FY2015 · CA · contact PI
Administrative Core$165,558
P50 · FY2015 · CA · contact PI
Developmental Research Program$138,397
P50 · FY2015 · CA · contact PI
SPORE in Brain Cancer$2,067,370
P50 · FY2014 · CA · contact PI
Administrative Core$163,816
P50 · FY2014 · CA · contact PI
Developmental Research Program$136,941
P50 · FY2014 · CA · contact PI
SPORE in Brain Cancer$2,042,322
P50 · FY2013 · CA · contact PI
Administrative Core$161,832
P50 · FY2013 · CA · contact PI
Developmental Research Program$135,282
P50 · FY2013 · CA · contact PI
CE: Animal Core$212,015
P50 · FY2012 · CA · contact PI
CE: Animal Core$201,762
P50 · FY2011 · CA · contact PI
Bone Marrow Stem Cells: Novel Treatment of Human Glioma$265,423
R01 · FY2010 · CA · contact PI
CE: Animal Core$202,961
P50 · FY2010 · CA · contact PI
Bone Marrow Stem Cells: Novel Treatment of Human Glioma$265,423
R01 · FY2009 · CA · contact PI
CE: Animal Core$202,078
P50 · FY2009 · CA · contact PI
Bone Marrow Stem Cells: Novel Treatment of Human Glioma$265,423
R01 · FY2008 · CA · contact PI
CE: Animal Core$120,166
P50 · FY2008 · CA · contact PI
Bone Marrow Stem Cells: Novel Treatment of Human Glioma$265,423
R01 · FY2007 · CA · contact PI
Regulation of p53-mediated apoptosis in gliomas$254,853
R01 · FY2007 · CA · contact PI
Bone Marrow Stem Cells: Novel Treatment of Human Glioma$273,350
R01 · FY2006 · CA · contact PI
Regulation of p53-mediated apoptosis in gliomas$262,464
R01 · FY2006 · CA · contact PI
Regulation of p53-mediated apoptosis in gliomas$268,780
R01 · FY2005 · CA
Regulation of p53-mediated apoptosis in gliomas$268,780
R01 · FY2004 · CA
Regulation of p53-mediated apoptosis in gliomas$260,247
R01 · FY2003 · CA
RADIOSENSITIZATION BY ANTIRAS SCFV-EXPRESSING ADENOVIRUS$207,445
R41 · FY2000 · CA